STIM - NASDAQ
Neuronetics, Inc.
$1.39
+2.3%Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
At a Glance
Live SnapshotNeuronetics, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Weak cash conversion. Significant portion of earnings not converting to cash—review working capital trends and capital intensity.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working Capital Impact
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
Neuronetics, Inc. Cash Flow Statement
STIM • NASDAQ
| Neuronetics, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||
-39.1M | -43.7M | -30.2M | -37.2M | -31.2M | -27.5M | -29M | -24.1M | -16.1M | -11.2M | |
3.5M | 2.1M | 2M | 1.6M | 1.1M | 941K | 1.1M | 882K | 596K | 673K | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.4M | -271K | 108K | |
6.8M | 5.6M | 7.3M | 8.7M | 7.9M | 4.4M | 3.4M | 1.7M | 496K | 161K | |
1.9M | 11.9M | 2.9M | 1.1M | 918K | 2M | 976K | 1.1M | 938K | 406K | |
6.6M | -6.8M | -14.1M | -5.1M | -6.6M | -8.3M | -6.9M | -1.6M | 3.2M | 1.3M | |
-20.4M | -31M | -32M | -30.7M | -28M | -28.4M | -30.5M | -20.6M | -11.1M | -8.5M | |
INVESTING ACTIVITIES | ||||||||||
-801K | -1.5M | -2.4M | -3.3M | -2.4M | -730K | -813K | -1M | -594K | -324K | |
(0.0) | -2.6M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-31K | 0.0 | 0.0 | 0.0 | 324K | 0.0 | -2.6M | 0.0 | 0.0 | 0.0 | |
31K | 1.6M | 1M | 10M | -7.8M | 0.0 | 2.6M | 0.0 | 0.0 | 0.0 | |
-801K | -2.4M | -1.3M | (6.7M) | -9.8M | -730K | -813K | -1M | -594K | -324K | |
FINANCING ACTIVITIES | ||||||||||
26.8M | 0.0 | 0.0 | 0.0 | 81M | 0.0 | 0.0 | 100M | 0.0 | 0.0 | |
9.6M | -2.5M | 23.8M | 0.0 | 0.0 | 2.5M | 0.0 | 0.0 | 10M | 5M | |
-594K | -4.3M | -1.1M | 207K | 2M | -131K | 2.4M | -3M | -980K | -104K | |
35.9M | -6.8M | 22.7M | 207K | 83M | 2.4M | 2.4M | 97M | 23.8M | 4.9M | |
CASH FLOW SUMMARY | ||||||||||
14.7M | -40.2M | -10.7M | -23.8M | 45.2M | -26.8M | -28.9M | 75.4M | 12.1M | -4M | |
19.5M | 59.7M | 70.3M | 94.1M | 49M | 75.7M | 104.6M | 29.1M | 17M | 21M | |
34.1M | 19.5M | 59.7M | 70.3M | 94.1M | 49M | 75.7M | 104.6M | 29.1M | 17M | |
-21.2M | -32.5M | -34.4M | -34M | -30.3M | -29.1M | -31.3M | -21.6M | -11.7M | -8.9M |
SEC Filings
STIM - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 29, 2026 | May 28, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 22, 2026 | May 18, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 05, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 09, 2026 | May 28, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 06, 2026 | March 31, 2026 | 2026 | |
S-3 S-3 N/A | March 17, 2026 | March 17, 2026 | ||
8-K 8-K 2026 N/A | March 17, 2026 | March 17, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 17, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 02, 2026 | March 02, 2026 | 2026 |
Related Guides
Continue your STIM research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.